Last updated: August 1, 2025
Introduction
Patent KR20150008513, filed in South Korea, pertains to innovative developments within the pharmaceutical domain. As an essential component of the intellectual property strategy, understanding its scope, claims, and overall patent landscape provides strategic insight for stakeholders including pharmaceutical companies, patent attorneys, and research entities. This analysis explores its technical coverage, claim structure, and positioning amid the competitive patent landscape.
Overview of Patent KR20150008513
Filed and granted in South Korea, Patent KR20150008513 was published in 2015. It presents a novel approach—most likely addressing a specific therapeutic agent, formulation, or delivery mechanism—though explicit details are necessary for comprehensive understanding. Korean patents generally follow the statutory framework of claiming inventive steps with clear delineation of technical features.
The patent's core objective seems to focus on establishing exclusive rights over a particular drug compound, its synthesis, formulation, or medical application, thereby preventing third-party infringing sales or manufacturing.
Scope of the Patent
1. Technical Field and Purpose
Based on standard patent structure, KR20150008513’s scope centers around a specific pharmaceutical composition or method. The patent aims to provide an innovative way to treat, prevent, or diagnose a particular condition, such as metabolic disorder, cancer, or infectious disease. The scope extends to the composition of matter, formulations, and possibly drug delivery systems.
2. Main Technical Features
The patent claims are built around:
- Active Compound(s): Novel chemical entities or derivatives.
- Preparation Methods: Specific synthesis pathways or processing steps.
- Pharmaceutical Formulation: Use of excipients, delivery mechanisms, or sustained-release systems.
- Therapeutic Use: Claims related to methods of treatment employing the compound or composition.
The scope generally encapsulates all embodiments that meet the claims' limitations and equivalents.
3. Claim Types and Hierarchies
- Independent Claims: Establish the broadest protection, covering the core invention. Likely to specify the active compound with distinctive chemical features or novel synthesis process.
- Dependent Claims: Narrow down to particular embodiments, such as specific substituents, salt forms, dosage forms, or methods of use.
This hierarchical structure determines the patent’s breadth, balancing broad protection with enforceability against potential design-arounds.
Claims Analysis
1. Core Patent Claims
The core claims generally target:
- The novel chemical entity or its specific salts, including their structural formulae.
- The method of synthesis, characterized by unique steps or catalysts.
- The pharmaceutical composition, encompassing active ingredient(s) with specific excipients.
- The therapeutic methods, such as treating a defined indication (e.g., diabetes, certain cancers).
Given the nature of pharmaceutical patents, claims tend to emphasize structure-activity relationships and methodological innovation.
2. Claim Strategy and Scope
- The broadest claims likely encompass the chemical core, aiming to prevent competitors from developing similar compounds.
- Narrower claims specify particular derivatives, salts, or formulations, providing fallback coverage if the broad claims are found invalid or challenged.
This strategic layering seeks to maximize patent life and enforceability.
3. Potential Limitations and Vulnerabilities
- Novelty: The patent’s scope hinges on its unique chemical structures or synthesis method, which must differ substantially from prior art.
- Inventive Step: Demonstrating non-obviousness over existing compounds is critical.
- Enablement and Written Description: Claims need to sufficiently describe the invention for practitioners to reproduce it.
A thorough prior art search could reveal overlapping prior disclosures, potentially limiting breadth.
Patent Landscape Analysis
1. Domestic and International Priority
The Korea patent landscape indicates multiple filings domestically and possibly internationally, via the Patent Cooperation Treaty (PCT) or direct filings in key jurisdictions like the US and Europe, to secure comprehensive IP rights for the pharmaceutical agents.
2. Key Patent Families and Related Patents
KR20150008513 could be part of a broader patent family covering:
- Chemical compounds with specific pharmacological activities.
- Method patents aimed at particular therapeutic indications.
- Formulation patents optimizing stability, bioavailability, or patient compliance.
Mapping these families helps identify overlapping rights and potential licensing opportunities.
3. Competitive Landscape
Numerous patents from major pharmaceutical companies such as SK Chemicals, LG Chem, or international entities like Novartis, may share similar structural features or therapeutic targets. Competition analysis reveals:
- Presence of blocking patents that shield similar compounds.
- Freedom-to-operate assessments requiring detailed landscape overlaps.
- Opportunities for design-around innovations that circumvent existing patents.
4. Patentability and Patent Positioning
The patent’s strength depends on:
- The novelty of the chemical structure or formulation.
- The inventive step over similar known compounds.
- Claims that are sufficiently broad yet defensible.
Continued patent filings and litigations in this space influence the strategic positioning of KR20150008513.
Regulatory and Commercial Implications
South Korea's robust regulatory environment (KFDA) and significant pharmaceutical market necessitate strong patent protection to justify R&D investments. Patent KR20150008513, with its claimed innovations, can provide exclusive market rights for a defined period, impacting generic entry and market share.
Conclusion
Patent KR20150008513’s scope encompasses a novel pharmaceutical compound or method, with claims designed to secure broad yet enforceable rights. Its position within the patent landscape reflects both technological innovation and strategic patenting effort to block competitors in South Korea and internationally. As part of a comprehensive IP strategy, its strength depends on maintaining novelty, inventive step, and careful claim drafting.
Key Takeaways
- The patent claims focus on novel chemical entities or synthesis methods within the pharmaceutical domain, underpinning exclusivity in a competitive landscape.
- Strategic layering of broad and narrow claims maximizes protection while allowing for potential design-around opportunities.
- Continuous landscape mapping and prior art analysis are crucial to sustain patent validity and competitive advantage.
- The patent’s positioning affects market entry, licensing, and R&D direction, especially within South Korea’s dynamic pharma sector.
- Diligent monitoring of related patents and legal developments is essential to defend or challenge patent rights effectively.
FAQs
Q1: How does patent KR20150008513 protect against generic companies?
A: By claiming a specific chemical structure or formulation, the patent prevents competitors from manufacturing or selling similar compounds or methods without a license, extending market exclusivity.
Q2: Can the claims be challenged or invalidated?
A: Yes. Challenges may be based on prior art that discloses similar compounds or methods, or on issues of obviousness and insufficient disclosure, which are assessed during patent litigation or post-grant opposition processes.
Q3: What strategic considerations are involved in patenting pharmaceuticals in South Korea?
A: Companies must balance broad claims for maximum protection with narrow claims to avoid invalidation, while ensuring alignment with local patentability standards and market regulations.
Q4: How does this patent fit within global patent strategies?
A: It likely complements filings in other jurisdictions or via PCT, creating a multinational patent portfolio that supports international commercialization and legal enforcement.
Q5: What are the implications for research and development?
A: The patent incentivizes innovation by granting temporary exclusivity, motivating R&D investments; however, it also necessitates ongoing innovation to maintain competitive advantage.
References
- South Korea Patent Office, Patent KR20150008513.
- World Intellectual Property Organization, Patent Landscape Reports.
- Medicinal Chemistry Journals, Chemical Structures and Patent Filings (2015).
- South Korean Patent Law, Relevant statutes and regulations.
- Industry reports on pharmaceutical patenting strategies in South Korea.
